what is known about trial:nct:NCT06217666

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) NCT06217666↗ Outcome: Ongoing

Computed from the knowledge API (getStudy); every record links to its source.